1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. CONCORD BIOTECH LTD.

Concord Biotech Ltd.

NSE: CONCORDBIO | BSE: 543960

Expensive Performer
Download real time

1748.50 81.60 (4.90%)

34.37% Fall from 52W High

1.5M NSE+BSE Volume

High volume today

NSE 30 May, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
18S
5W
2O
1T
18,292.1

Market Cap

Market Runner Up
49.2

PE TTM

Above industry Median
2.4

PEG TTM

PEG TTM is much higher than 1
11.5

Price to Book

High in industry
0.7

Beta 1Year

Very Low volatility
Estimates Beat
Concord Biotech's Q4 profit and revenue beat Forecaster estimates by 22.9% and 14.9%, respectively See details

Concord Biotech Ltd. - CONCORDBIO - stock price prediction, stock forecast, target price, analyst ratings from 5 analysts

Concord Biotech Ltd. has a share price target of Rs 1907, revenue growth forecast of 15.0%, and profit growth estimate of 14.8% for FY25, based on top 5 analyst calls.

Forecaster Screeners